{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-23-013870","form_type":"8-K","ticker":null,"cik":"0001617765","company_name":"EVOME MEDICAL TECHNOLOGIES INC.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.684048+00:00","generated_at":"2026-06-13T21:20:30.243104+00:00","sec_items":["1.01","5.02","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Salona Global terminates CEO Luke Faulstick, appoints Michael Seckler as interim CEO","bullets":["Luke Faulstick terminated as President and CEO effective June 13, 2023; remains on the board.","Michael Seckler appointed Interim CEO; previously senior executive at Ferring/FerGene.","Joseph Martinez terminated as SVP Legal, General Counsel, Secretary; available as hourly consultant.","Company prioritizing cash flow from operations and debt restructuring per chairman.","Seckler receives $100k salary, up to $200k variable comp, and 250,000 options at CAD$0.25."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-23-013870","json":"https://secwatch.observer/filing/0001062993-23-013870.json","markdown":"https://secwatch.observer/filing/0001062993-23-013870.md","text":"https://secwatch.observer/filing/0001062993-23-013870.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T21:20:30.243104+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e9d60c31e","claim":"Luke Faulstick was terminated as President and Chief Executive Officer at EVOME MEDICAL TECHNOLOGIES INC..","evidence_excerpt":"On June 13, 2023, Salona Global Medical Device Corporation (the \"Company\") exercised its right to terminate the employment of Luke Faulstick as the Company's President and Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"d57009f66f","claim":"Joseph Martinez was terminated as Senior Vice President, Legal & Compliance, General Counsel and Secretary at EVOME MEDICAL TECHNOLOGIES INC..","evidence_excerpt":"on June 13, 2023 he ceased to hold the titles of Senior Vice President, Legal & Compliance, General Counsel and Secretary of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Senior Vice President, Legal & Compliance, General Counsel and Secretary"}],"fact_type":"executive_change"},{"claim_id":"f411c29ebb","claim":"Michael Seckler was appointed as Interim Chief Executive Officer at EVOME MEDICAL TECHNOLOGIES INC..","evidence_excerpt":"On June 13, 2023, upon terminating Mr. Faulstick, the Company appointed Michael Seckler, 58, to the position of Interim Chief Executive Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}